Alto Ingredients (ALTO) Stock Forecast, Price Target & Predictions
ALTO Stock Forecast
Alto Ingredients stock forecast is as follows: an average price target of $3.50 (represents a 127.27% upside from ALTO’s last price of $1.54) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
ALTO Price Target
The average price target for Alto Ingredients (ALTO) is $3.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $3.50 to $3.50. This represents a potential 127.27% upside from ALTO's last price of $1.54.
ALTO Analyst Ratings
According to 2 Wall Street analysts, Alto Ingredients's rating consensus is 'Buy'. The analyst rating breakdown for ALTO stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Alto Ingredients Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 07, 2024 | Eric Stine | Craig-Hallum | $3.50 | $1.83 | 91.17% | 127.27% |
The latest Alto Ingredients stock forecast, released on May 07, 2024 by Eric Stine from Craig-Hallum, set a price target of $3.50, which represents a 91.17% increase from the stock price at the time of the forecast ($1.83), and a 127.27% increase from ALTO last price ($1.54).
Alto Ingredients Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $3.50 |
| Last Closing Price | $1.54 | $1.54 | $1.54 |
| Upside/Downside | -100.00% | -100.00% | 127.27% |
In the current month, the average price target of Alto Ingredients stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Alto Ingredients's last price of $1.54. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 07, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Nov 07, 2023 | Needham | Buy | Buy | Hold |
Alto Ingredients's last stock rating was published by Craig-Hallum on May 07, 2024. The company gave ALTO a "Buy" rating, the same as its previous rate.
Alto Ingredients Financial Forecast
Alto Ingredients Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $273.63M | $318.13M | $317.30M | $313.89M | $328.44M | $336.88M | - | $308.12M | $385.49M | $305.56M | $298.11M | $218.73M | $168.82M | $204.73M | $212.07M | $311.40M | $357.62M | $365.16M | $346.30M | $355.80M |
| Avg Forecast | $278.60M | $281.70M | $270.50M | $256.20M | $268.62M | $267.57M | $232.58M | $217.28M | $292.96M | $308.71M | $298.25M | $297.80M | $342.36M | $311.44M | $320.85M | $341.40M | $323.30M | $267.01M | $288.09M | $264.16M | $234.25M | $210.31M | $174.20M | $269.79M | $369.80M | $374.28M | $357.92M | $352.85M |
| High Forecast | $286.27M | $289.46M | $277.95M | $263.26M | $276.02M | $274.94M | $238.99M | $223.26M | $301.03M | $317.21M | $306.47M | $306.00M | $351.79M | $320.01M | $320.85M | $356.96M | $338.04M | $279.19M | $301.22M | $276.20M | $244.93M | $219.89M | $182.14M | $282.09M | $386.66M | $391.34M | $374.23M | $368.93M |
| Low Forecast | $270.93M | $273.94M | $263.05M | $249.14M | $261.22M | $260.20M | $226.18M | $211.30M | $284.89M | $300.20M | $290.03M | $289.60M | $332.93M | $302.86M | $320.85M | $325.84M | $308.57M | $254.85M | $274.96M | $252.13M | $223.58M | $200.72M | $166.26M | $257.50M | $352.95M | $357.23M | $341.61M | $336.77M |
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | 0.93% | 1.03% | 1.06% | 1.05% | 0.96% | 1.08% | - | 0.90% | 1.19% | 1.14% | 1.03% | 0.83% | 0.72% | 0.97% | 1.22% | 1.15% | 0.97% | 0.98% | 0.97% | 1.01% |
Alto Ingredients's average Quarter revenue forecast for Mar 24 based on 0 analysts is $217.28M, with a low forecast of $211.30M, and a high forecast of $223.26M. ALTO's average Quarter revenue forecast represents a -20.59% decrease compared to the company's last Quarter revenue of $273.63M (Dec 23).
Alto Ingredients EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | $-5.35M | $-4.33M | $9.27M | $-11.03M | $-27.95M | $-27.70M | - | $3.73M | $43.62M | $2.61M | $15.24M | $12.42M | $-13.01M | $27.46M | $28.66M | $-10.03M | $-23.95M | $-10.13M | $9.26M | $3.97M |
| Avg Forecast | $-53.13K | $-53.72K | $-51.58K | $-48.85K | $-51.22K | $-51.02K | $-44.35K | $-41.43K | $-55.86K | $-58.87K | $-56.87K | $-56.79K | $-65.28K | $6.45M | $-61.18K | $7.68M | $-61.65K | $5.87M | $9.96M | $-50.37K | $-44.67K | $-40.10K | $-33.22K | $-51.45K | $-70.52K | $-71.37K | $-68.25K | $-67.28K |
| High Forecast | $-51.66K | $-52.24K | $-50.16K | $-47.51K | $-49.81K | $-49.62K | $-43.13K | $-40.29K | $-54.33K | $-57.24K | $-55.31K | $-55.22K | $-63.49K | $7.75M | $-61.18K | $9.21M | $-58.84K | $7.04M | $11.95M | $-48.08K | $-42.63K | $-38.27K | $-31.70K | $-49.10K | $-67.30K | $-68.12K | $-65.14K | $-64.22K |
| Low Forecast | $-54.59K | $-55.20K | $-53.00K | $-50.20K | $-52.63K | $-52.43K | $-45.57K | $-42.57K | $-57.40K | $-60.49K | $-58.44K | $-58.35K | $-67.08K | $5.16M | $-61.18K | $6.14M | $-64.46K | $4.69M | $7.97M | $-52.67K | $-46.71K | $-41.93K | $-34.73K | $-53.79K | $-73.73K | $-74.62K | $-71.36K | $-70.35K |
| Surprise % | - | - | - | - | - | - | - | - | 95.77% | 73.50% | -162.99% | 194.18% | 428.11% | -4.29% | - | 0.49% | -707.46% | 0.44% | 1.53% | -246.62% | 291.22% | -684.81% | -862.73% | 195.04% | 339.63% | 141.99% | -135.65% | -59.03% |
0 analysts predict ALTO's average Quarter EBITDA for Sep 23 to be $-58.87K, with a high of $-57.24K and a low of $-60.49K. This is -100.64% lower than Alto Ingredients's previous annual EBITDA (Jun 23) of $9.27M.
Alto Ingredients Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - | $-18.95M | $-3.49M | $7.59M | $-7.68M | $-33.07M | $-21.78M | - | $-2.91M | $36.15M | $-3.13M | $8.39M | $4.68M | $-20.20M | $15.21M | $14.96M | $-25.10M | $-41.09M | $-27.33M | $-7.65M | $-12.89M |
| Avg Forecast | $4.41M | $2.94M | $3.67M | $-2.20M | $4.04M | $2.57M | $-7.35M | $-10.66M | $-5.88M | $6.98M | $-3.92M | $-7.59M | $-4.16M | $-7.75M | $6.79M | $-5.35M | $22.38M | $-7.05M | $5.48M | $7.84M | $17.37M | $18.95M | $-14.59M | $-41.96M | $-19.70M | $-12.04M | $-15.32M | $-25.17M |
| High Forecast | $4.57M | $3.04M | $3.81M | $-2.13M | $4.19M | $2.66M | $-7.09M | $-10.27M | $-5.67M | $7.23M | $-3.78M | $-7.32M | $-4.02M | $-6.20M | $6.79M | $-4.28M | $23.70M | $-5.64M | $6.58M | $8.31M | $18.40M | $20.07M | $-13.73M | $-39.47M | $-18.53M | $-11.33M | $-14.42M | $-23.68M |
| Low Forecast | $4.25M | $2.83M | $3.54M | $-2.28M | $3.90M | $2.48M | $-7.61M | $-11.04M | $-6.09M | $6.73M | $-4.06M | $-7.87M | $-4.31M | $-9.30M | $6.79M | $-6.42M | $21.05M | $-8.46M | $4.38M | $7.38M | $16.34M | $17.83M | $-15.46M | $-44.44M | $-20.87M | $-12.75M | $-16.23M | $-26.67M |
| Surprise % | - | - | - | - | - | - | - | - | 3.22% | -0.50% | -1.94% | 1.01% | 7.94% | 2.81% | - | 0.54% | 1.62% | 0.44% | 1.53% | 0.60% | -1.16% | 0.80% | -1.03% | 0.60% | 2.09% | 2.27% | 0.50% | 0.51% |
Alto Ingredients's average Quarter net income forecast for Sep 23 is $6.98M, with a range of $6.73M to $7.23M. ALTO's average Quarter net income forecast represents a -8.08% decrease compared to the company's last Quarter net income of $7.59M (Jun 23).
Alto Ingredients SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | $8.52M | $8.49M | $7.91M | $7.88M | $7.55M | $7.40M | - | $7.63M | $9.41M | $-5.53M | $7.23M | $7.01M | $6.74M | $6.40M | $8.63M | $10.21M | $11.82M | $8.69M | $6.71M | $8.23M |
| Avg Forecast | $7.52M | $7.61M | $7.31M | $6.92M | $7.26M | $7.23M | $6.28M | $5.87M | $7.91M | $8.34M | $8.06M | $8.04M | $9.25M | $-13.69M | $8.67M | $15.69M | $8.73M | $-12.45M | $4.72M | $7.13M | $6.33M | $5.68M | $4.71M | $7.29M | $9.99M | $10.11M | $9.67M | $9.53M |
| High Forecast | $7.73M | $7.82M | $7.51M | $7.11M | $7.46M | $7.43M | $6.45M | $6.03M | $8.13M | $8.57M | $8.28M | $8.26M | $9.50M | $-10.96M | $8.67M | $18.83M | $9.13M | $-9.96M | $5.67M | $7.46M | $6.62M | $5.94M | $4.92M | $7.62M | $10.44M | $10.57M | $10.11M | $9.96M |
| Low Forecast | $7.32M | $7.40M | $7.10M | $6.73M | $7.06M | $7.03M | $6.11M | $5.71M | $7.69M | $8.11M | $7.83M | $7.82M | $8.99M | $-16.43M | $8.67M | $12.56M | $8.33M | $-14.94M | $3.78M | $6.81M | $6.04M | $5.42M | $4.49M | $6.95M | $9.53M | $9.65M | $9.23M | $9.10M |
| Surprise % | - | - | - | - | - | - | - | - | 1.08% | 1.02% | 0.98% | 0.98% | 0.82% | -0.54% | - | 0.49% | 1.08% | 0.44% | 1.53% | 0.98% | 1.06% | 1.13% | 1.83% | 1.40% | 1.18% | 0.86% | 0.69% | 0.86% |
Alto Ingredients's average Quarter SG&A projection for Mar 24 is $5.87M, based on 0 Wall Street analysts, with a range of $5.71M to $6.03M. The forecast indicates a -31.14% fall compared to ALTO last annual SG&A of $8.52M (Dec 23).
Alto Ingredients EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | $-0.26 | $-0.05 | $0.10 | $-0.10 | $-0.45 | $-0.30 | - | $-0.04 | $0.51 | $-0.05 | $0.11 | $0.06 | $-0.30 | $0.25 | $0.27 | $-0.47 | $-0.85 | $-0.58 | $-0.17 | $-0.29 |
| Avg Forecast | $0.06 | $0.04 | $0.05 | $-0.03 | $0.06 | $0.04 | $-0.10 | $-0.14 | $-0.08 | $0.10 | $-0.05 | $-0.10 | $-0.06 | - | $0.09 | $0.14 | $0.31 | $0.12 | $0.15 | $0.11 | $0.24 | $0.26 | $-0.20 | $-0.57 | $-0.27 | $-0.17 | $-0.21 | $-0.34 |
| High Forecast | $0.06 | $0.04 | $0.05 | $-0.03 | $0.06 | $0.04 | $-0.10 | $-0.14 | $-0.08 | $0.10 | $-0.05 | $-0.10 | $-0.05 | - | $0.09 | $0.14 | $0.32 | $0.13 | $0.16 | $0.11 | $0.25 | $0.28 | $-0.19 | $-0.54 | $-0.25 | $-0.16 | $-0.20 | $-0.32 |
| Low Forecast | $0.06 | $0.04 | $0.05 | $-0.03 | $0.05 | $0.03 | $-0.10 | $-0.15 | $-0.08 | $0.09 | $-0.06 | $-0.11 | $-0.06 | - | $0.09 | $0.13 | $0.29 | $0.11 | $0.14 | $0.10 | $0.22 | $0.24 | $-0.21 | $-0.61 | $-0.29 | $-0.17 | $-0.22 | $-0.37 |
| Surprise % | - | - | - | - | - | - | - | - | 3.25% | -0.50% | -1.88% | 0.97% | 7.94% | -90.01% | - | -0.30% | 1.66% | -0.42% | 0.75% | 0.56% | -1.26% | 0.96% | -1.35% | 0.82% | 3.15% | 3.52% | 0.81% | 0.84% |
According to 0 Wall Street analysts, Alto Ingredients's projected average Quarter EPS for Sep 23 is $0.10, with a low estimate of $0.09 and a high estimate of $0.10. This represents a -5.00% decrease compared to ALTO previous annual EPS of $0.10 (Jun 23).
Alto Ingredients Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ALTO | Alto Ingredients | $1.54 | $3.50 | 127.27% | Buy |
| DNMR | Danimer Scientific | $0.40 | $0.90 | 125.00% | Hold |
| OEC | Orion Engineered Carbons | $16.91 | $32.00 | 89.24% | Buy |
| LTHM | Livent | $16.51 | $27.33 | 65.54% | Buy |
| ECVT | Ecovyst | $6.68 | $10.00 | 49.70% | Buy |
| ASH | Ashland | $86.70 | $117.30 | 35.29% | Buy |
| AVTR | Avantor | $26.88 | $35.71 | 32.85% | Buy |
| KWR | Quaker Chemical | $164.69 | $197.50 | 19.92% | Buy |
| SQM | Sociedad Química y Minera de Chile | $38.23 | $45.75 | 19.67% | Buy |
| FUL | H.B. Fuller Company | $80.78 | $85.60 | 5.97% | Buy |
| AXTA | Axalta Coating Systems | $34.80 | $36.73 | 5.55% | Buy |
| ESI | Element Solutions | $25.62 | $25.60 | -0.08% | Buy |
| CBT | Cabot | $104.75 | $99.50 | -5.01% | Hold |
| BCPC | Balchem | $171.82 | $152.00 | -11.54% | Buy |
| KRO | Kronos Worldwide | $11.22 | $9.00 | -19.79% | Sell |
| PRM | Perimeter Solutions, SA | $11.97 | $7.00 | -41.52% | Hold |
ALTO Forecast FAQ
Is Alto Ingredients a good buy?
Yes, according to 2 Wall Street analysts, Alto Ingredients (ALTO) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of ALTO's total ratings.
What is ALTO's price target?
Alto Ingredients (ALTO) average price target is $3.5 with a range of $3.5 to $3.5, implying a 127.27% from its last price of $1.54. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Alto Ingredients stock go up soon?
According to Wall Street analysts' prediction for ALTO stock, the company can go up by 127.27% (from the last price of $1.54 to the average price target of $3.5), up by 127.27% based on the highest stock price target, and up by 127.27% based on the lowest stock price target.
Can Alto Ingredients stock reach $2?
ALTO's average twelve months analyst stock price target of $3.5 supports the claim that Alto Ingredients can reach $2 in the near future.
What are Alto Ingredients's analysts' financial forecasts?
Alto Ingredients's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $986.05M (high $1.01B, low $958.89M), average EBITDA is $-188K (high $-183K, low $-193K), average net income is $-11.39M (high $-10.509M, low $-12.272M), average SG&A $26.63M (high $27.37M, low $25.9M), and average EPS is $-0.155 (high $-0.143, low $-0.167). ALTO's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.09B (high $1.12B, low $1.06B), average EBITDA is $-207K (high $-202K, low $-213K), average net income is $8.82M (high $9.29M, low $8.34M), average SG&A $29.36M (high $30.17M, low $28.55M), and average EPS is $0.12 (high $0.126, low $0.114).
Did the ALTO's actual financial results beat the analysts' financial forecasts?
Based on Alto Ingredients's last annual report (Dec 2023), the company's revenue was $1.22B, beating the average analysts forecast of $1.2B by 2.11%. Apple's EBITDA was $6.07M, missing the average prediction of $-228K by -2757.29%. The company's net income was $-28.005M, beating the average estimation of $-10.41M by 169.01%. Apple's SG&A was $32.66M, beating the average forecast of $32.35M by 0.97%. Lastly, the company's EPS was $-0.38, beating the average prediction of $-0.142 by 168.24%. In terms of the last quarterly report (Dec 2023), Alto Ingredients's revenue was $273.62M, missing the average analysts' forecast of $292.96M by -6.60%. The company's EBITDA was $-5.35M, beating the average prediction of $-55.864K by 9476.83%. Alto Ingredients's net income was $-18.945M, beating the average estimation of $-5.879M by 222.26%. The company's SG&A was $8.52M, beating the average forecast of $7.91M by 7.71%. Lastly, the company's EPS was $-0.26, beating the average prediction of $-0.08 by 225.00%